Mixed treatment comparison of repeated measurements of a continuous endpoint: an example using topical treatments for primary open-angle glaucoma and ocular hypertension

被引:28
作者
Dakin, Helen A. [1 ]
Welton, Nicky J. [2 ]
Ades, A. E. [2 ]
Collins, Sarah
Orme, Michelle
Kelly, Steven [3 ]
机构
[1] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England
[2] Univ Bristol, Sch Social & Community Med, Bristol BS8 1TH, Avon, England
[3] Pfizer Ltd, Surrey, England
关键词
mixed treatment comparison meta-analysis; network meta-analysis; meta-regression; panel data; primary open-angle glaucoma; ocular hypertension; ELEVATED INTRAOCULAR-PRESSURE; GEL-FORMING SOLUTION; RANDOMIZED CLINICAL-TRIAL; PROSTAGLANDIN ANALOGS; OPHTHALMIC SOLUTION; FIXED COMBINATION; DOSE-RESPONSE; TRAVOPROST; 0.004-PERCENT; PARALLEL-GROUP; TIMOLOL GEL;
D O I
10.1002/sim.4284
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mixed treatment comparison (MTC) meta-analyses estimate relative treatment effects from networks of evidence while preserving randomisation. We extend the MTC framework to allow for repeated measurements of a continuous endpoint that varies over time. We used, as a case study, a systematic review and meta-analysis of intraocular pressure (IOP) measurements from randomised controlled trials evaluating topical ocular hypotensives in primary open-angle glaucoma or ocular hypertension because IOP varies over the day and over the treatment course, and repeated measurements are frequently reported. We adopted models for conducting MTC in WinBUGS (The BUGS Project, Cambridge, UK) to allow for repeated IOP measurements and to impute missing standard deviations of the raw data using the predictive distribution from observations with standard deviations. A flexible model with an unconstrained baseline for IOP variations over time and time-invariant random treatment effects fitted the data well. We also adopted repeated measures models to allow for class effects; assuming treatment effects to be exchangeable within classes slightly improved model fit but could bias estimated treatment effects if exchangeability assumptions were not valid. We enabled all timepoints to be included in the analysis, allowing for repeated measures to increase precision around treatment effects and avoid bias associated with selecting timepoints for meta-analysis. The methods we developed for modelling repeated measures and allowing for missing data may be adapted for use in other MTC meta-analyses. Copyright (C) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:2511 / 2535
页数:25
相关论文
共 104 条
[1]   Bayesian methods for evidence synthesis in cost-effectiveness analysis [J].
Ades, AE ;
Sculpher, M ;
Sutton, A ;
Abrams, K ;
Cooper, N ;
Welton, N ;
Lu, GB .
PHARMACOECONOMICS, 2006, 24 (01) :1-19
[2]  
ADES AE, INTRO TOMIXED TREATM
[3]   A comparative study of bimatoprost and travoprost:: Effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients [J].
Alagoz, Gursoy ;
Gurel, Kamil ;
Bayer, Atilla ;
Serin, Didem ;
Celebi, Serdal ;
Kukner, Sahap .
OPHTHALMOLOGICA, 2008, 222 (02) :88-95
[4]  
*ALC LAB UK LTD, 2007, SUMM PROD CHAR TRAV
[5]  
*ALL LTD, 2010, SUMM PROD CHAR LUM 0
[6]  
[Anonymous], GLAUC DIAGN MAN CHRO
[7]   Efficacy and Tolerability of Prostaglandin Analogs A Meta-analysis of Randomized Controlled Clinical Trials [J].
Aptel, Florent ;
Cucherat, Michel ;
Denis, Philippe .
JOURNAL OF GLAUCOMA, 2008, 17 (08) :667-673
[8]   The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension [J].
Arcieri, E. S. ;
Pierre Filho, P. T. P. ;
Wakamatsu, T. H. ;
Costa, V. P. .
EYE, 2008, 22 (02) :179-183
[9]   The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution [J].
Barnebey, HS ;
Orengo-Nania, S ;
Flowers, BE ;
Samples, J ;
Mallick, S ;
Landry, TA ;
Bergamini, MVW .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 140 (01) :1-7
[10]  
Bartlett JD, 1999, J GLAUCOMA, V8, P388